News

"MTPA’s Radicava shows long-term benefit in ALS trials" was originally created and published by Clinical Trials Arena, a ...
Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, are among the most ...
David Crean, Chief Business Officer at MediciNova (Nasdaq: MNOV), a late-stage, global biopharmaceutical company that is ...
Former Detroit Red Wings forward Mark Kirton, who enjoyed the most productive seasons of his NHL career with the franchise, has tragically lost his battle against ALS and passed away Sunday at just 67 ...
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...
Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...